All three AML lines significantly suppressed the expression of both CYP3A4 and CDA in both the human BMSC line F/STRO (Figure 1A and B respectively) and the primary human BMSCs (Figure 1C and D respectively). The gene discussed is CYP3A4; the disease is acute myeloid leukemia.